[The protective effect of phosphonic compounds (sodium-fosfomycin and arginine-fosfomycin) in experimental infections in the mouse].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005578:Fosfomycin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D007668:Kidney / Q000382:microbiology; D008099:Liver / Q000382:microbiology; D008168:Lung / Q000382:microbiology; D008297:Male; D051379:Mice; D013154:Spleen / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus
D000900:Anti-Bacterial Agents; D005578:Fosfomycin; C028351:arginine fosfomycin
Effetto protettivo di composti fosfonici (fosfomicina sodica ed arginin-fosfomicina) in infezioni sperimientali del topo